Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-02

Clinical Trial Update: Comparison of Efficacy of Topical Westerhoff Formula Cream Vs Topical 4% Hydroquinone for the Treatment of Melasma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing the efficacy of Westerhoff Formula Cream versus 4% hydroquinone topical for facial melasma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroquinone 4% topical (hydroquinone)
  • Westerhoff Formula Cream

Snippet

Sponsor: Pak Emirates Military Hospital | Conditions: Melasma (Facial Melasma) | Phase 4 | Status: COMPLETED